Variant report

Variant	nsv947799
Chromosome Location	chr10:29286902-29288806
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:29279625..29282236-chr10:29283754..29288089,3	MCF-7	breast:

Extended variants
information (count: 97 )
Associated
traits (count: 40 )

Variant overlapped rSNPs/rCNVs (count:97 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs148368827	chr10:29286905-29286906	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs538096938	chr10:29286907-29286908	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs556715514	chr10:29286929-29286930	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs11007348	chr10:29286953-29286954	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs12249923	chr10:29286988-29286989	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs12768476	chr10:29287014-29287015	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs572529690	chr10:29287075-29287076	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs539797583	chr10:29287082-29287083	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs555386257	chr10:29287087-29287088	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs534546547	chr10:29287132-29287133	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs544123796	chr10:29287152-29287153	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs372592614	chr10:29287167-29287168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs562677920	chr10:29287170-29287171	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs150492077	chr10:29287223-29287224	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs183038129	chr10:29287229-29287230	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs551956728	chr10:29287266-29287267	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs35177271	chr10:29287267-29287268	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs397758306	chr10:29287272-29287273	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs560541585	chr10:29287310-29287311	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs187363103	chr10:29287320-29287321	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs549389957	chr10:29287324-29287325	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs371922494	chr10:29287339-29287340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs191650127	chr10:29287344-29287345	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs11007349	chr10:29287378-29287379	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs58155329	chr10:29287399-29287400	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs183049390	chr10:29287477-29287478	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs188132623	chr10:29287480-29287481	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs192409791	chr10:29287483-29287484	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs566192107	chr10:29287488-29287489	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs533581848	chr10:29287505-29287506	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs555338218	chr10:29287530-29287531	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs573878410	chr10:29287533-29287534	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs138192994	chr10:29287537-29287538	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs556149757	chr10:29287556-29287557	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs577933489	chr10:29287575-29287576	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs545175711	chr10:29287663-29287664	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs788051	chr10:29287696-29287697	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs146079837	chr10:29287706-29287707	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs1052828	chr10:29287707-29287708	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs561320492	chr10:29287711-29287712	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs529319435	chr10:29287714-29287715	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs531573341	chr10:29287716-29287717	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs550474675	chr10:29287725-29287726	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs571803925	chr10:29287734-29287735	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs2001681	chr10:29287771-29287772	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs183707570	chr10:29287774-29287775	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs566274553	chr10:29287796-29287797	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs553004847	chr10:29287799-29287800	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs34624755	chr10:29287814-29287815	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs533618911	chr10:29287837-29287838	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:40)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22048815	CNVD
Myelofibrosis	22110671	CNVD

Chromatin state (count:15 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:29273800-29290800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr10:29282400-29291000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr10:29286000-29287000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
4	chr10:29286000-29287200	Enhancers	HepG2	liver
5	chr10:29286000-29287600	Enhancers	A549	lung
6	chr10:29286000-29295400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr10:29286800-29287400	Weak transcription	Placenta Amnion	Placenta Amnion
8	chr10:29286800-29288000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
9	chr10:29287200-29287600	Enhancers	Fetal Lung	lung
10	chr10:29287400-29287600	Enhancers	Placenta Amnion	Placenta Amnion
11	chr10:29287600-29288800	Weak transcription	Fetal Lung	lung
12	chr10:29287600-29296400	Weak transcription	A549	lung
13	chr10:29288000-29289000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
14	chr10:29288200-29289000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
15	chr10:29288800-29289000	Enhancers	Fetal Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links